Neuralink, Elon Musk's brain implant venture, is reaching out to major U.S. neurosurgery centers to potentially begin testing its devices on humans, according to a Reuters report. Before that can happen though, the U.S. government needs to grant the company approval, which is far from certain. In 2022, the U.S. Food and Drug Administration rejected its application to proceed with human trials due to safety concerns. Neuralink has been working to address those concerns ever since.
Wooly Mammoths, Dodo Birds, and Thylacines - Oh my! Ben Lamm, CEO and Co-Founder of Colossal, talks De-extinction and his company's plan to "Re-wild" the world.
The U.S. Secretary of Energy, Jennifer Granholm, joins Cheddar to discuss the state of clean energy and keeping battery manufacturing in America. Watch!
